Publications
- Treatment of Relapsed/Refractory Hodgkin Lymphoma: Real-World Data from the Czech Republic and Slovakia2019 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma2018 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Brentuximab vedotin treatment in clinical practice2018 | Third Faculty of Medicine
- Treatment of Relapsed and Refractory Hodgkin Lymphoma - Recommendations of the Czech Hodgkin Lymphoma Study Group2016 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Treatment and Prognosis of Relapsed or Refractory Hodgkin Lymphoma Patients Ineligible for Stem Cell Transplantation2014 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Advances in hodgkin lymphoma treatment2013 | Third Faculty of Medicine
- Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma2011 | Central Library of Charles University, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Treatment of patients with relapsed/refractory Hodgkin lymphoma2011 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Reduction of toxicity in first-line treatment of advanced stage Hodgkin lymphoma2011 | Third Faculty of Medicine
- Can We Use EBV-DNA Monitoring to Predict Disease Relapse in EBV-Positive Hodgkin Lymphoma Patients?2010 | Third Faculty of Medicine, Second Faculty of Medicine
Loading network view...